Activation-induced nonresponsiveness: A Th-dependent regulatory chekpoint in the CTL response

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1190-1197

  Tham, Ee Loon ^a   Shrikant, Protul ^a   Mescher, Matthew F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036467459     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1190     Document Type: Article

References (45)

1. T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors
2. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
3. + T-helper and a T-killer cell
4. Help for cytotoxic T-cell responses is mediated by CD40 signaling
5. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
6. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
7. + cytotoxic T lymphocytes in the absence of exogenous help
8. + T cells
9. + cells after a transient response to antigen
10. + T-cell-deficient mice
11. + cytotoxic T-cell responses during chronic viral infection
12. + T cells
13. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
14. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
15. + T cell and IL-2-dependent mechanism
16. + T cells have a major "post-licensing" role in CTL-mediated anti-tumor immunity
17. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
18. + T cells
19. + T cells are poorly costimulated by ICAM-1
20. + T cells become nonresponsive (anergic) following activation in the presence of costimulation
21. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
22. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative non-responsiveness
23. Clonal expansion vs functional clonal inactivation
24. + T cells: Efficacy is limited by migration away from the site and induction of nonresponsiveness
25. T cell receptor antagonist peptides induce positive selection
26. Introduction of soluble protein into the class I pathway of antigen processing and presentation
27. Signaling alterations in activation-induced nonresponsive CD8 T cells
28. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
29. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
30. CTLA-4 ligation blocks CD28-dependent T cell activation
31. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
32. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
33. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4
34. + T cells
35. + T cells
36. 2-terminal kinase and mitogen-activated protein kinase signaling pathways
37. Epitope affinity for MHC class I determines helper requirement for CTL priming
38. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
39. + T cell death
40. Viral immune evasion due to persistence of activated T cells without effector function
41. Assessing CD8 T cell number and dysfunction in the presence of antigen
42. + T cells upon in vivo stimulation with allogeneic tumor
43. + T cell response
44. + T cells
45. Licence to kill